Financial News · Live Terminal

Page 157 of 193

BofA Securities Adjusts Price Target on Armstrong World Industries to $210 From $216

Armstrong World Industries (AWI) has an average rating of overweight and mean price target of $206.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $179.71, Change: $+0.04, Percent Change: +0.02%

$AWI

Australia20d ago

BofA Securities Cuts Price Target on Meta Platforms to $820 From $885, Maintains Buy Rating

Meta Platforms (META) has an average rating of buy and mean price target of $847.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $675.22, Change: $-13.33, Percent Change: -1.94%

$META

Australia20d ago

BofA Securities Raises Price Target on Amazon.com to $298 From $275, Maintains Buy Rating

Amazon.com (AMZN) has an average rating of buy and mean price target of $281.85, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $247.36, Change: $-3.20, Percent Change: -1.28%

$AMZN

Australia20d ago

BofA Securities Adjusts Price Target on Allegion Public to $157 From $185

Allegion Public (ALLE) has an average rating of overweight and mean price target of $173.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $145.23, Change: $+0.91, Percent Change: +0.63%

$ALLE

Australia20d ago

AnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge

AnaptysBio (ANAB) said Monday that it has completed the spinoff of its biopharma operations business First Tracks Biotherapeutics.Under the terms of the spinoff, Anaptys shareholders received one share of First Tracks for every share of Anaptys owned as of the close of business on April 6. First Tracks Bio common stock were set to begin trading Monday on the Nasdaq Global Select Market under the ticker symbol "TRAX."The company said it will now exclusively manage its financial collaborations with GSK (GSK) and Vanda for cancer medicine Jemperli and generalized pustular psoriasis treatment imsidolimab, respectively.Shares of AnaptysBio were up close to 8% in recent trading on Monday.Price: $48.39, Change: $+3.39, Percent Change: +7.53%

$ANAB$GSK$TRAX

Australia20d ago

Market Chatter: Eni, Repsol Reach Deal With Venezuela to Boost Output, Export LNG From Offshore Field

Eni (E) and Repsol have reached a deal with the Venezuelan government to begin exporting natural gas from the country's Perla field in the Gulf of Venezuela, shipping the fuel in the form of liquefied natural gas from a floating terminal, Bloomberg reported Monday, citing sources familiar with the matter.The deal, which was signed in mid-March, will allow the two companies to start exporting once they boost supplies for domestic use to 645 million cubic feet per day from 585 million currently. They plan to install two more platforms in the field by 2028 and begin exporting once they attain production of 1.2 billion cubic feet per day, the sources said.The two companies have also been assured that they will be compensated for billions of dollars worth of gas that they have extracted in the field for domestic use in the past years, according to the report. The agreement also extends their operation lease to 2051 from 2036, the sources said.The two companies aim to submit a final development plan for the field to state-owned oil firm Petroleos de Venezuela by June, the report said.Eni confirmed to Bloomberg that the companies reached an agreement with the government to boost gas production and begin exports.Eni and Repsol did not immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $52.42, Change: $+0.13, Percent Change: +0.25%

Australia20d ago

Choice Hotels International Collaborating With Amazon Web Services to Integrate AI in Its Operations

Choice Hotels International (CHH) said Monday it is integrating AI across its operations in collaboration with Amazon's (AMZN) Amazon Web Services.Financial details were not provided.Choice Hotels said it is using the AgentCore platform backed by AWS that allows it to use intelligent agents that can retrieve information and automate workflows.Price: $118.92, Change: $-0.29, Percent Change: -0.24%

$AMZN$CHH

Australia20d ago

Meta, CBRE Launch Data Center Workforce Training Program

Meta Platforms (META) and CBRE Group (CBRE) said Monday they have launched a multiyear program to recruit and train technicians to support the construction of Meta's data centers in the US.Financial terms of the partnership were not provided.The companies said CBRE will set up training sites across the country beginning this summer, with participants prepared for roles installing fiber-optic systems, network equipment, and other infrastructure at Meta data center projects.The program, dubbed LevelUp, is intended to address a shortage of skilled workers needed for data center construction, with trainees expected to work through Meta's contractor network, the companies said.Price: $675.70, Change: $-12.85, Percent Change: -1.87%

$CBRE$META

Australia20d ago

Silvaco Says SmartSpice Platform Deployed at Taiwan Incubation Center

Silvaco (SVCO) said Monday that its SmartSpice circuit simulation platform has been deployed by Taiwan-based Industrial Technology Research Institute at its Nankang IC Design Incubation Center.The company said SmartSpice will enable precise circuit simulation and verification for next-generation microcontroller unit designs developed by startups within the incubator program.Financial details related to the partnership were not provided.Shares of Silvaco were up 1% in early trading Monday.Price: $8.62, Change: $+0.09, Percent Change: +1.00%

$SVCO

Australia20d ago

Viasat Confirms Launch of Final ViaSat-3 Satellite

Viasat (VSAT) said Monday its ViaSat-3 F3 satellite is scheduled for launch on April 27, aboard a SpaceX Falcon Heavy rocket from NASA's Kennedy Space Center, marking the final satellite in its ViaSat-3 constellation.The satellite is designed to deliver over 1 terabit per second of throughput across the Asia-Pacific region, expanding Viasat's high-capacity broadband network for commercial, mobility and government customers.Following launch, it will undergo several months of orbit-raising and in-orbit testing before entering service, expected in late summer of this year.Shares of Viasat were up 1.2% in Monday trading.Price: $63.63, Change: $+0.78, Percent Change: +1.24%

$VSAT

Australia20d ago

Nano-X Imaging Signs Strategic Deal With Howard Technology to Rollout 3D Imaging System; Shares Fall Pre-Bell

Nano-X Imaging (NNOX) said Monday it has signed a strategic commercial agreement with Howard Technology Solutions to support the commercial rollout of its 3D medical imaging system Nanox.ARC.Financial terms of the agreement were not disclosed.Under the deal, Howard will market and deploy 300 Nanox.ARC systems over a three-year period, which will include 60 in the first year.Shares of Nano-X Imaging were down more than 14% pre-bell.Price: $2.45, Change: $-0.40, Percent Change: -14.04%

$NNOX

Australia20d ago

Rayonier Advanced Materials Explores Strategic Moves; Creates Interim Office of Chief Executive

Rayonier Advanced Materials (RYAM) said Monday it is exploring a strategic alternatives that could include selling all or part of the company, a strategic investment, a merger or other business combination, and other strategic or financial alternatives."The board has not set a timetable for completion of the strategic review and does not intend to provide updates unless and until it is determined that disclosure is appropriate or required by law," Rayonier said in a statement.The company also said that its board of directors has set up an interim office of the chief executive following the resignation of President and Chief Executive Scott Sutton.The office includes Chief Financial Officer Marcus Moeltner, Vice President of Manufacturing Operations Michael Osborne, Senior Vice President of Biomaterials Christian Ribeyrolle, and General Counsel R. Colby Slaughter.Shares of Rayonier Advanced Materials were up over 5% pre-bell Monday.Price: $10.80, Change: $+0.59, Percent Change: +5.78%

$RYAM

Australia20d ago

Sable Offshore Expects $180 Million in Capital Expenditures Through December, Oil Transportation Begins

Sable Offshore (SOC) said Monday that capital expenditure across its assets is expected to be around $180 million from April through December this year.The company also said oil transportation through two segments of the Santa Ynez Pipeline System has begun.The company said the 40 wells currently online at the Harmony and Heritage offshore platforms are producing an average of 750 barrels of oil per day per well.Once all 74 production wells are online, Sable said it expects average production per well to be around 700 barrels of oil per day.Sable also said it expects Platform Hondo to come online in June with an estimated fully ramped production rate of around 10,000 barrels of oil per day.The company also said it plans to conclude a refinancing of its senior secured term loan in the second quarter of 2026.Shares of the company were up 3.7% in Monday premarket trading.

$SOC

Australia20d ago

Prelude Therapeutics Prices $90 Million Underwritten Offering

Prelude Therapeutics (PRLD) said Monday it has priced an underwritten offering of about 18 million shares of voting common stock at $4.44 per share, along with pre-funded warrants to purchase up to about 2.3 million shares at $4.4399 each, for gross proceeds of about $90 million.The offering is expected to close on or about Tuesday, the company said.Net proceeds will be used for working capital and general corporate purposes, including the development of its product candidates, Prelude Therapeutics said.Shares of Prelude Therapeutics were 11% higher in Monday premarket trading.

$PRLD

Australia20d ago

TechCreate, pQCee Collaborate on Quantum-Safe POS Terminals; Shares Rise Pre-Bell

TechCreate (TCGL) said Monday it plans to collaborate with pQCee to use post-quantum cryptography algorithms for its QR hybrid point-of-sale terminals.Under the collaboration, the company said it will explore integration of quantum-safe encryption into real-time payment systems.Shares of TechCreate were over 13% higher in Monday premarket trading.Price: $196.71, Change: $+23.87, Percent Change: +13.81%

$TCGL

Australia20d ago

Fermi Names Marius Haas as Chairman; CEO Toby Neugebauer Steps Down; Shares Down Pre-Bell

Fermi (FRMI) said Monday that it has named lead independent board director Marius Haas as chairman, effective immediately.The company also said that Chief Executive and co-founder Toby Neugebauer has stepped down but remains a member of the board.During the transition, a new office of the CEO composed of several people will serve as an operational leadership team, the company said.Fermi said its board has initiated a formal search process for its next CEO.The company added that it is in negotiations with a candidate to serve as interim Chief Financial Officer after the resignation of Miles Everson, who will remain as a board director.Shares of the company were down more than 20% in recent premarket trading Monday.Price: $5.19, Change: $-1.36, Percent Change: -20.76%

$FRMI

Australia20d ago

Coventry Group Reports Higher Fiscal Q3 Sales; Shares Hit All-Time Low

Coventry Group (ASX:CYG) reported fiscal third-quarter sales of AU$88.2 million, up 1.4% from a year earlier, according to a Monday filing with the Australian bourse.The company also reported earnings before interest, taxes, depreciation, and amortization of AU$2.1 million for the quarter, down 11% from a year earlier, per the filing.Coventry Group said the benefits of its ongoing cost-cutting program are becoming "increasingly evident" in financial performance, and it has identified "significant further opportunities" for efficiency savings.The company's shares were down nearly 2% in recent Monday trade, hitting an all-time low.

$ASX:CYG

Australia22d ago

Top Cryptocurrencies Rise; Bitcoin Tops $77,000 Level

Major digital assets rose Friday, with Bitcoin (BTC-USD) exceeding the $77,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 2.3% in the past 24 hours. The Nasdaq 100 gained 1.2%, the S&P 500 increased 1.1%, and the Dow Jones Industrial Average climbed up 1.8%.Bitcoin rose 2.8% to $77,353, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume surged 28.9% to $54.38 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, gained 3.2% to $2,430.XRP (XRP-USD) climbed 1.8%, BNB (BNB-USD) rose 0.8%, while Solana (SOL-USD) fell 0.7%. Dogecoin (DOGE-USD) increased 0.7%, and Cardano (ADA-USD) advanced 0.6%.The US 10-year Treasury yield stood at 4.242% at 3 p.m. ET Friday, down from 4.305% Thursday, while the five-year yield fell to 3.836% from 3.911%.The total market value of the cryptocurrency industry rose 2.4% in the past 24 hours to $2.61 trillion, with trading volume gaining 2.6% to $158.98 billion.Price: $77363.53, Change: $+2211.54, Percent Change: +2.94%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD

Australia22d ago

Zai Lab to Present Zoci Data From Ongoing Phase 1 Trial at AACR Annual Meeting

Zai Lab (ZLAB) said Friday data from its ongoing phase 1 trial of zocilurtatug pelitecan showed a 53.7% intracranial objective response rate in patients with small cell lung cancer and brain metastases.The findings, which showed that the zoci drug candidate triggers intracranial lesion regression and reduced tumor size, will be presented at the American Association for Cancer Research Annual Meeting in San Diego, according to a statement.The potential zoci drug conjugate also demonstrated a manageable safety profile, with most adverse events reported as low grade, the company said.The company's phase 1b/2 trial data also showcased antitumor activity in patients with extrapulmonary neuroendocrine carcinomas, with an objective response rate of 38.2%, according to the company.Price: $24.06, Change: $+0.56, Percent Change: +2.38%

$ZLAB

Australia22d ago

Market Chatter: Palantir Selected to Compete on New FAA AI Tool

Palantir Technologies (PLTR), Thales, and Air Space Intelligence were selected by the US Federal Aviation Administration to compete on a new artificial intelligence tool for air traffic management, Bloomberg reported Friday, citing a person familiar with the matter.The FAA has received $12.5 billion from Congress for the project but it needs about $20 billion more to complete the overhaul, according to the report.Palantir did not immediately respond to a request for comment by.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $147.00, Change: $+4.24, Percent Change: +2.97%

$PLTR

Showing 3121-3140 of 3847